First Eagle Investment Management LLC raised its holdings in shares of Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 196.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 328,824 shares of the company's stock after acquiring an additional 217,923 shares during the quarter. First Eagle Investment Management LLC owned approximately 0.84% of Viemed Healthcare worth $2,637,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also recently modified their holdings of the company. Bard Associates Inc. grew its stake in shares of Viemed Healthcare by 1.3% during the 4th quarter. Bard Associates Inc. now owns 349,526 shares of the company's stock valued at $2,803,000 after acquiring an additional 4,474 shares during the period. Bailard Inc. bought a new position in shares of Viemed Healthcare in the fourth quarter worth approximately $255,000. Rice Hall James & Associates LLC bought a new position in shares of Viemed Healthcare in the fourth quarter worth approximately $2,083,000. Rhumbline Advisers increased its stake in shares of Viemed Healthcare by 15.5% in the fourth quarter. Rhumbline Advisers now owns 46,836 shares of the company's stock worth $376,000 after purchasing an additional 6,275 shares in the last quarter. Finally, R Squared Ltd bought a new stake in shares of Viemed Healthcare during the 4th quarter valued at $41,000. Institutional investors own 74.24% of the company's stock.
Viemed Healthcare Price Performance
Viemed Healthcare stock traded down $0.22 during mid-day trading on Thursday, hitting $7.36. The stock had a trading volume of 70,740 shares, compared to its average volume of 133,751. Viemed Healthcare, Inc. has a one year low of $6.21 and a one year high of $9.81. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03. The firm has a market capitalization of $290.88 million, a P/E ratio of 27.26 and a beta of 1.50. The firm's 50 day moving average is $7.94 and its 200 day moving average is $8.20.
Viemed Healthcare Company Profile
(
Free Report)
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Featured Stories
Before you consider Viemed Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.
While Viemed Healthcare currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
